{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:46:11Z","timestamp":1794033971009,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>With the availability of first disease-modifying treatments, evidence on costs across the entire Alzheimer's Continuum, especially for early disease stages, becomes increasingly important to inform healthcare planning, resource allocation, and policy decisions. This study assessed costs and cost-associated factors in patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI) and Alzheimer's Disease (AD) dementia compared to healthy controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The German DELCODE cohort study assessed clinical data, healthcare resource use, and informal care provision. Costs were calculated from payer and societal perspectives using standardized unit costs, and multivariate regression analyses identified cost-associated factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>From a payer perspective, costs were elevated by 26% for SCD (adjusted mean 5,976\u20ac [95%CI\u00a04,598-7,355\u20ac]), 85% for MCI (8,795\u20ac [6,200-11,391\u20ac]) and 36% for AD (6,454\u20ac [2,796-10,111\u20ac]) compared to controls (4,754\u20ac [3,586-5,922\u20ac]). Societal costs were elevated by 52% for SCD (adjusted mean 8,377\u20ac [95%CI\u00a06,009-10,746\u20ac]), 170% for MCI (14,886\u20ac [9,524-20,248\u20ac]) and 307% for AD (22,481\u20ac [9,994-34,969\u20ac]) compared to controls (5,522\u20ac [3,814-7,230\u20ac]). APOE e4 negative patients showed higher costs compared to APOE e4 positive patients. Hypertension was associated with higher costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Healthcare costs are already elevated in early subjective and objective cognitive impairment, driven by formal and informal care. The study emphasizes the importance of early interventions to reduce the economic burden and delay progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01785-9","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T08:06:44Z","timestamp":1750925204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factors"],"prefix":"10.1186","volume":"17","author":[{"given":"Eva","family":"Gl\u00e4ser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Kilimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Platen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Brosseron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Buerger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Coenjaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"D\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Fliessbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Frommann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gemenetzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Hellmann-Regen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enise I.","family":"Incesoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Janowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Spottke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike Jakob","family":"Spruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Michalowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"issue":"2","key":"1785_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"The Lancet Public Health."},{"issue":"7","key":"1785_CR2","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/alz.12901","volume":"19","author":"A Wimo","year":"2023","unstructured":"Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, et al. The worldwide costs of dementia in 2019. Alzheimers Dement. 2023;19(7):2865\u201373.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1785_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener. 2020;15(1):40.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1785_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1001\/jamaneurol.2017.4198","volume":"75","author":"LG Apostolova","year":"2018","unstructured":"Apostolova LG, Risacher SL, Duran T, Stage EC, Goukasian N, West JD, et al. Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis. JAMA Neurol. 2018;75(3):328\u201341.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1785_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM. ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med. 2019;17(1):64.","journal-title":"BMC Med"},{"issue":"10452","key":"1785_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572\u2013628.","journal-title":"Lancet"},{"issue":"6","key":"1785_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1785_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/acps.12336","volume":"130","author":"AJ Mitchell","year":"2014","unstructured":"Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130(6):439\u201351.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"1785_CR9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2014;10(6):844\u201352.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1785_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jalz.2018.10.003","volume":"15","author":"RER Slot","year":"2019","unstructured":"Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, et al. Subjective cognitive decline and rates of incident Alzheimer\u2019s disease and non-Alzheimer\u2019s disease dementia. Alzheimers Dement. 2019;15(3):465\u201376.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1785_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1212\/01.wnl.0000252358.03285.9d","volume":"68","author":"P Fischer","year":"2007","unstructured":"Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology. 2007;68(4):288\u201391.","journal-title":"Neurology"},{"issue":"4","key":"1785_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1212\/WNL.0000000000001788","volume":"85","author":"K Tifratene","year":"2015","unstructured":"Tifratene K, Robert P, Metelkina A, Pradier C, Dartigues JF. Progression of mild cognitive impairment to dementia due to AD in clinical settings. Neurology. 2015;85(4):331\u20138.","journal-title":"Neurology"},{"issue":"1","key":"1785_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40273-022-01212-z","volume":"41","author":"L J\u00f6nsson","year":"2023","unstructured":"J\u00f6nsson L, Tate A, Frisell O, Wimo A. The Costs of Dementia in Europe: An Updated Review and Meta-analysis. Pharmacoeconomics. 2023;41(1):59\u201375.","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"1785_CR14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jalz.2015.01.007","volume":"11","author":"CL Leibson","year":"2015","unstructured":"Leibson CL, Long KH, Ransom JE, Roberts RO, Hass SL, Duhig AM, et al. Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study. Alzheimers Dement. 2015;11(8):917\u201332.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1785_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jalz.2016.08.009","volume":"13","author":"TGN Ton","year":"2017","unstructured":"Ton TGN, DeLeire T, May SG, Hou N, Tebeka MG, Chen E, et al. The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment. Alzheimers Dement. 2017;13(3):217\u201324.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1785_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JAD-191212","volume":"75","author":"RL Robinson","year":"2020","unstructured":"Robinson RL, Rentz DM, Andrews JS, Zagar A, Kim Y, Bruemmer V, et al. Costs of Early Stage Alzheimer\u2019s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1. J Alzheimers Dis. 2020;75(2):437\u201350.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1785_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/alz.12400","volume":"18","author":"KH Long","year":"2022","unstructured":"Long KH, Smith C, Petersen R, Emerson J, Ransom J, Mielke MM, et al. Medical and nursing home costs: From cognitively unimpaired through dementia. Alzheimers Dement. 2022;18(3):393\u2013407.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1785_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12430","volume":"15","author":"JM Chandler","year":"2023","unstructured":"Chandler JM, Rentz DM, Zagar A, Kim Y, Schwartz RL, Fillit H. Disease progression and costs at the 3-year follow-up of the GERAS-US study. Alzheimers Dement (Amst). 2023;15(2): e12430.","journal-title":"Alzheimers Dement (Amst)."},{"issue":"4","key":"1785_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.14283\/jpad.2024.68","volume":"11","author":"FH Frech","year":"2024","unstructured":"Frech FH, Li G, Juday T, Ding Y, Mattke S, Khachaturian A, et al. Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States. J Prev Alzheimers Dis. 2024;11(4):983\u201391.","journal-title":"J Prev Alzheimers Dis."},{"key":"1785_CR20","doi-asserted-by":"crossref","unstructured":"Aye S, Frisell O, Zetterberg H, Skillb\u00e4ck TB, Kern S, Eriksdotter M, et al. Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study. Pharmacoeconomics. 2024;43:153\u2013169.","DOI":"10.1007\/s40273-024-01443-2"},{"key":"1785_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2318-9-43","volume":"9","author":"FB Waldorff","year":"2009","unstructured":"Waldorff FB, Siersma V, Waldemar G. Association between subjective memory complaints and health care utilisation: a three-year follow up. BMC Geriatr. 2009;9:43.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1785_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-022-00969-x","volume":"14","author":"V Dauphinot","year":"2022","unstructured":"Dauphinot V, Potashman M, Levitchi-Benea M, Su R, Rubino I, Krolak-Salmon P. Economic and caregiver impact of Alzheimer\u2019s disease across the disease spectrum: a cohort study. Alzheimers Res Ther. 2022;14(1):34.","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"1785_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13195-017-0314-2","volume":"10","author":"F Jessen","year":"2018","unstructured":"Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, et al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer\u2019s disease (DELCODE). Alzheimers Res Ther. 2018;10(1):15.","journal-title":"Alzheimers Res Ther."},{"issue":"3","key":"1785_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1785_CR25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/a-2169-1480","volume":"86","author":"LK Muntendorf","year":"2024","unstructured":"Muntendorf LK, Brettschneider C, Konnopka A, K\u00f6nig HH. Updating standardized unit costs from a societal perspective for health economic evaluation. Gesundheitswesen. 2024;86(5):389\u201393.","journal-title":"Gesundheitswesen"},{"key":"1785_CR26","unstructured":"(WIdO) WIdA. GKV-Arzneimittelindex. Available from: https:\/\/www.wido.de\/publikationen-produkte\/analytik\/arzneimittel-klassifikation\/arzneimittel-stammdatei\/. Accessed 09 Feb 2024."},{"key":"1785_CR27","unstructured":"(Destatis) SB. Verbraucherpreisindex: Deutschland, Jahre 2024. Available from: https:\/\/www-genesis.destatis.de\/datenbank\/online\/statistic\/61111\/table\/61111-0001.\u00a0Accessed 09 Feb 2024."},{"issue":"5","key":"1785_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"3","key":"1785_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323\u20139.","journal-title":"J Gerontol"},{"issue":"3","key":"1785_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.274","volume":"3","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O, et al. CSF A\u00df42\/A\u00df40 and A\u00df42\/A\u00df38 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol. 2016;3(3):154\u201365.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1785_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/fampra\/11.3.260","volume":"11","author":"P D'Ath","year":"1994","unstructured":"D\u2019Ath P, Katona P, Mullan E, Evans S, Katona C. Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract. 1994;11(3):260\u20136.","journal-title":"Fam Pract."},{"issue":"2","key":"1785_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0895-4356(93)90053-4","volume":"46","author":"RA Washburn","year":"1993","unstructured":"Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46(2):153\u201362.","journal-title":"J Clin Epidemiol"},{"key":"1785_CR33","unstructured":"Lubben J, Gironda M. Centrality of Social Ties to the Health and Well-Being of Older Adults. In: Berkman L, Harooyta L, editors. Social Work and Health Care in an Aging World. New York: Springer Press; 2003. p. 319\u2013350."},{"key":"1785_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1472-6963-12-165","volume":"12","author":"L Schwarzkopf","year":"2012","unstructured":"Schwarzkopf L, Menn P, Leidl R, Wunder S, Mehlig H, Marx P, et al. Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data. BMC Health Serv Res. 2012;12:165.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"1785_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13195-017-0290-6","volume":"9","author":"B Michalowsky","year":"2017","unstructured":"Michalowsky B, Flessa S, Hertel J, Goetz O, Hoffmann W, Teipel S, et al. Cost of diagnosing dementia in a German memory clinic. Alzheimers Res Ther. 2017;9(1):65.","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"1785_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13195-020-00673-8","volume":"12","author":"TM Liew","year":"2020","unstructured":"Liew TM. Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia. Alzheimers Res Ther. 2020;12(1):107.","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"1785_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10198-017-0869-7","volume":"19","author":"B Michalowsky","year":"2018","unstructured":"Michalowsky B, Flessa S, Eichler T, Hertel J, Dreier A, Zwingmann I, et al. Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial. Eur J Health Econ. 2018;19(1):87\u2013102.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1785_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13195-020-00706-2","volume":"12","author":"MA Dubbelman","year":"2020","unstructured":"Dubbelman MA, Jutten RJ, Tomaszewski Farias SE, Amariglio RE, Buckley RF, Visser PJ, et al. Decline in cognitively complex everyday activities accelerates along the Alzheimer\u2019s disease continuum. Alzheimers Res Ther. 2020;12(1):138.","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"1785_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/JAD-180131","volume":"66","author":"SC Mallo","year":"2018","unstructured":"Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, et al. Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment. J Alzheimers Dis. 2018;66(1):83\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1785_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/jgs.12132","volume":"61","author":"CW Zhu","year":"2013","unstructured":"Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Aisen PS. Health-related resource use and costs in elderly adults with and without mild cognitive impairment. J Am Geriatr Soc. 2013;61(3):396\u2013402.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1785_CR41","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","volume":"61","author":"ME Charlson","year":"2008","unstructured":"Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234\u201340.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"1785_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.whi.2015.06.001","volume":"25","author":"Z Yang","year":"2015","unstructured":"Yang Z, Levey A. Gender Differences: A Lifetime Analysis of the Economic Burden of Alzheimer\u2019s Disease. Womens Health Issues. 2015;25(5):436\u201340.","journal-title":"Womens Health Issues"},{"issue":"1","key":"1785_CR43","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1186\/s12877-022-03466-w","volume":"22","author":"RS Falck","year":"2022","unstructured":"Falck RS, Percival AG, Tai D, Davis JC. International depiction of the cost of functional independence limitations among older adults living in the community: a systematic review and cost-of-impairment study. BMC Geriatr. 2022;22(1):815.","journal-title":"BMC Geriatr"},{"issue":"6","key":"1785_CR44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ana.21696","volume":"65","author":"E Kok","year":"2009","unstructured":"Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, et al. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol. 2009;65(6):650\u20137.","journal-title":"Ann Neurol"},{"issue":"7399","key":"1785_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485(7399):512\u20136.","journal-title":"Nature"},{"issue":"3","key":"1785_CR46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1474-9726.2011.00689.x","volume":"10","author":"AM Kulminski","year":"2011","unstructured":"Kulminski AM, Culminskaya I, Ukraintseva SV, Arbeev KG, Arbeeva L, Wu D, et al. Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell. 2011;10(3):533\u201341.","journal-title":"Aging Cell"},{"issue":"3","key":"1785_CR47","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3233\/JAD-210434","volume":"82","author":"XR Chen","year":"2021","unstructured":"Chen XR, Shao Y, Sadowski MJ. Segmented Linear Mixed Model Analysis Reveals Association of the APOE?4 Allele with Faster Rate of Alzheimer\u2019s Disease Dementia Progression. J Alzheimers Dis. 2021;82(3):921\u201337.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1785_CR48","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1532-5415.2005.53301.x","volume":"53","author":"KM Hayden","year":"2005","unstructured":"Hayden KM, Zandi PP, Lyketsos CG, Tschanz JT, Norton MC, Khachaturian AS, et al. Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc. 2005;53(6):935\u201342.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"1785_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219668","volume":"14","author":"FJ Wolters","year":"2019","unstructured":"Wolters FJ, Yang Q, Biggs ML, Jakobsdottir J, Li S, Evans DS, et al. The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE). PLoS ONE. 2019;14(7): e0219668.","journal-title":"PLoS ONE"},{"issue":"6","key":"1785_CR50","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11906-013-0398-4","volume":"15","author":"D Gasecki","year":"2013","unstructured":"Gasecki D, Kwarciany M, Nyka W, Narkiewicz K. Hypertension, brain damage and cognitive decline. Curr Hypertens Rep. 2013;15(6):547\u201358.","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"1785_CR51","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/jamaophthalmol.2019.0446","volume":"137","author":"AR Morse","year":"2019","unstructured":"Morse AR, Seiple W, Talwar N, Lee PP, Stein JD. Association of Vision Loss With Hospital Use and Costs Among Older Adults. JAMA Ophthalmol. 2019;137(6):634\u201340.","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"1785_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.diabres.2015.02.016","volume":"108","author":"R Hu","year":"2015","unstructured":"Hu R, Shi L, Pierre G, Zhu J, Lee DC. Diabetesand medical expenditures among non-institutionalized U.S. adults. Diabetes Res Clin Pract. 2015;108(2):223\u201334.","journal-title":"Diabetes Res Clin Pract."},{"issue":"4","key":"1785_CR53","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3233\/JAD-231055","volume":"99","author":"JR Thyrian","year":"2024","unstructured":"Thyrian JR, Boekholt M, Biernetzky O, Blotenberg I, Teipel S, Killimann I, et al. Informal Caregivers of People with Dementia in Germany: Psychosocial Characteristics and Unmet Needs. J Alzheimers Dis. 2024;99(4):1235\u201342.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1785_CR54","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/heapro\/day062","volume":"34","author":"C Stormacq","year":"2019","unstructured":"Stormacq C, Van den Broucke S, Wosinski J. Does health literacy mediate the relationship between socioeconomic status and health disparities? Integrative review Health Promot Int. 2019;34(5):e1\u201317.","journal-title":"Integrative review. Health Promot Int."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01785-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01785-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01785-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T09:03:32Z","timestamp":1750928612000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01785-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1785"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01785-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethical committees of the medical faculties of all participating sites: the ethical committees of Berlin (Charit\u00e9, Universit\u00e4tsmedizin Berlin), Bonn, Cologne, G\u00f6ttingen, Magdeburg, Munich (Ludwig-Maximilians-University), Rostock, and T\u00fcbingen. The process was led and coordinated by the ethical committee of the medical faculty of the University of Bonn. The trial registration number at the ethical committee in Bonn is 117\/13.All participants or their representatives provided written informed consent. DELCODE was conducted in accordance with the Helsinki Declaration of 1975.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}